Successful immunotherapy of an intraocular tumor in mice

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5250-5254

  Schurmans, Luc R H M ^a   Den Boer, Annemieke Th ^a   Diehl, Linda ^a   Van Der Voort, Ellen I H ^a   Kast, W Martin ^b   Melief, Cornelis J M ^a   Toes, René E M ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; INTRAOCULAR TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTERIOR CHAMBER; EYE NEOPLASMS; IMMUNIZATION; IMMUNOTHERAPY, ADOPTIVE; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032742541     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Streilein, J. W. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv. Ophthalmol., 35: 67-73, 1990.
2. Streilein, J. W., Ksander, B. R., and Taylor, A. W. Immune deviation in relation to ocular immune privilege. J. Immunol., 158; 3557-3560, 1997.
3. Niederkorn, J. Y. Immunoregulation of intraocular tumours. Eye, 11: 249-254, 1997.
4. Reese, A. B., Archila, E. A., Jones, I. S., and Cooper, W. C. Necrosis of malignant melanoma of the choroid. Am. J. Ophthalmol., 69: 91-104, 1970.
5. Jensen, O. A., and Andersen, S. R. Spontaneous regression of a malignant melanoma of the choroid. Acta. Ophthalmol., 52: 173-182, 1974.
6. Khodadoust, A. A., Roozitalab, H. M., Smith, R. E., and Green, W. R. Spontaneous regression of retinoblastoma. Surv. Ophthalmol., 21: 467-478, 1977.
7. Steuhl, K. P., Rohrbach, J. M., Knorr, M., and Thiel, H. J. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology, 100: 208-215, 1993.
8. Carrel, S., Schreyer, M., Gross, N., and Zografos, L. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res., 10: 81-89, 1990.
9. Kan-Mitchell, J., Rao, N., Albert, D. M., Van Eldik, L. J., and Taylor, C. R. S100 immunophenotypes of uveal melanomas. Invest. Ophthalmol. Vis. Sci., 31: 1492-1496, 1990.
10. Ma, D., Alizadeh, H., Comerford, S. A., Gething, M. J., Sambrook, J. F., Anand, R., and Niederkorn, J. Y. Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes. Curr. Eye Res., 13: 361-369, 1994.
11. Niederkorn, J. Y. T cell subsets involved in the rejection of metastases arising from intraocular melanomas in mice. Invest. Ophthalmol. Vis. Sci., 28: 1397-1403, 1987.
12. Niederkorn, J. Y., Knisely, T. L., and Mayhew, E. Immune rejection of metastases arising from intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci., 27: 1355-1361, 1986.
13. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., and Melief, C. J. Eradication of adenovirus El-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell, 59: 603-614, 1989.
14. Toes, R. E., Offringa, R., Blom, R. J., Brandt, R. M., van der Eb, A. J., Melief, C. J., and Kast, W. M. An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol., 154: 3396-3405, 1995.
15. Niederkorn, J., Streilein, J. W., and Shadduck, J. A. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest. Ophthalmol. Vis. Sci., 20: 355-363, 1981.
16. Feltkamp, M. C., Smits, H. L., Vierboom, M. P., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
17. Schulz, M., Zinkernagel, R. M., and Hengartner, H. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 88: 991-993, 1991.
18. Gausepohl, H., Kraft, M., Boulin, C., and Frank, R. W. Automated multiple peptide synthesis with BOP activation. In: J. E. Rivier and G. R. Marshall (eds.), 11th American Peptide Symposium, pp. 1003-1005. Leiden, the Netherlands: ESCOM, Science Publishers BV, 1990.
19. Streilein, J. W., Takeuchi, M., and Taylor, A. W. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum. Immunol., 52: 138-143, 1997.
20. Bottino, C., Vitale, M., Pende, D., Biassoni, R., and Moretta, A. Receptors for HLA class I molecules in human NK cells. Semin. Immunol., 7: 67-73, 1995.
21. Toes, R. E., Blom, R. J., Offringa, R., Kast, W. M., and Melief, C. J. Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. J. Immunol., 156: 3911-3918, 1996.
22. Streilein, J. W. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye, 9: 236-240, 1995.
23. Streilein, J. W. Immune regulation and the eye: a dangerous compromise. FASEB J., 1: 199-208, 1987.
24. Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R., and Heath, W. R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med., 188: 409-414, 1998.
25. Niederkorn, J. Y., and Meunier, P. C. Spontaneous immune rejection of intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci., 26: 877-884, 1985.
26. Niederkorn, J. Y. The immunopathology of intraocular tumour rejection. Eye, 5: 186-192, 1991.
27. Knisely, T. L., Luckenbach, M. W., Fischer, B. J., and Niederkorn, J. Y. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol., 138: 4515-4523, 1987.
28. Niederkorn, J. Y., and Streilein, J. W. Adoptive transfer of immunity to intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci., 25: 336-342, 1984.
29. Niederkorn, J. Y., Streilein, J. W., and Kripke, M. L. Promotion of syngeneic intraocular tumor growth in mice by anterior chamber-associated immune deviation. J. Natl. Cancer. Inst., 71: 193-199, 1983.
30. Ksander, B. R., Mammolenti, M. M., and Streilein, J. W. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function. Transplantation, 52: 128-133, 1991.